Paediatric Grand RoundsMay 8

2
PAEDIATRIC GRAND ROUNDS Alberta Children's Hospital May 8, 2013 0830 ~ 0930h Kinsmen Learning Centre Auditorium on 4th Floor TRIALS AND TRIBULATIONS OF DRUG DEVELOPMENT: LESSONS LEARNED FROM THE HISTORY OF ANTI-SEIZURE MEDICATIONS Jong M. Rho, MD Professor of Pediatrics and Clinical Neurosciences Dr. Robert Haslam Chair in Child Neurology University of Calgary Faculty of Medicine Head, Section of Paediatric Neurology, Alberta Children’s Hospital Learning Objectives 1. To provide an overview of drug development by the pharmaceutical industry 2. To review the history of anti-seizure drugs, both in terms of success and failures 3. To summarize current and future opportunities for changing the strategic models for novel drug development This session is being offered by Telehealth (Videoconference). To register as a participant, and/or to request a Telehealth connection for your location: follow this link to the AHS “Calendar of Upcoming Videoconferences”: https://vcscheduler.ca/ahs/ . On the calendar, scroll down and to the right of this event, click on “Click here to register as a participant”. Complete and submit the online registration and Telehealth location request. Help is also available at: [email protected] For more information about this and other Child Health Professional Educational Events via Telehealth, visit: http://fcrc.albertahealthservices.ca/pro_telehealth_calendar.php . Posters, Handouts and Evaluations are posted and can be printed for distribution and individual use.

description

Paediatric Grand Rounds May 8, 2013 0830 ~ 0930h

Transcript of Paediatric Grand RoundsMay 8

PAEDIATRIC GRAND ROUNDS Alberta Children's Hospital

May 8, 2013 0830 ~ 0930h

Kinsmen Learning Centre Auditorium on 4th Floor

TRIALS AND TRIBULATIONS OF DRUG DEVELOPMENT:

LESSONS LEARNED FROM THE HISTORY OF ANTI-SEIZURE MEDICATIONS

Jong M. Rho, MD Professor of Pediatrics and Clinical Neurosciences

Dr. Robert Haslam Chair in Child Neurology University of Calgary Faculty of Medicine

Head, Section of Paediatric Neurology, Alberta Children’s Hospital

Learning Objectives

1. To provide an overview of drug development by the pharmaceutical industry 2. To review the history of anti-seizure drugs, both in terms of success and failures 3. To summarize current and future opportunities for changing the strategic models for novel drug development

This session is being offered by Telehealth (Videoconference). To register as a participant, and/or to request a Telehealth connection for your location: follow this link to the AHS “Calendar of Upcoming Videoconferences”: https://vcscheduler.ca/ahs/. On the calendar, scroll down and to the right of this event,

click on “Click here to register as a participant”. Complete and submit the online registration and Telehealth location request.

Help is also available at: [email protected] For more information about this and other Child Health Professional Educational Events via Telehealth, visit: http://fcrc.albertahealthservices.ca/pro_telehealth_calendar.php.

Posters, Handouts and Evaluations are posted and can be printed for distribution and individual use.

2888 Shaganappi Trail NW Calgary, AB T3B 6A8 • www.ucalgary.ca

UNIVERSITY OF

CALGARY Department of Paediatrics

Alberta Children’s Hospital

PAEDIATRIC GRAND ROUNDS EVALUATION FORM

PRESENTED BY: DATE: May 8, 2013

Jong M. Rho, MD Professor of Pediatrics and Clinical Neurosciences Dr. Robert Haslam Chair in Child Neurology University of Calgary Faculty of Medicine Head, Section of Paediatric Neurology, Alberta Children’s Hospital TRIALS AND TRIBULATIONS OF DRUG DEVELOPMENT: LESSONS LEARNED FROM THE HISTORY OFANTI-SEIZURE MEDICATIONS

Please complete the following questions and return this questionnaire at the end of the session. • The learning objectives were clearly stated: YES NO • Speaker communicated in a manner that kept my interest: YES NO • Speaker was organized and well prepared: YES NO • Information presented in a logical/sequential manner: YES NO • The audio visual materials were clear and enhanced the presentation: YES NO • Key points were summarized at the end: YES NO

• My practice will change as a result of attending this session: YES NO NA • Amount of information presented was appropriate for the allocated time: YES NO

Paediatricians - Name: _______________________________________ please print (to track Maintenance of Certification Credits) (If we can’t read your name we can’t apply your credits) Residents/Fellows - Name: ______________________________________ please print Please provide comments about this Grand Rounds presentation as well as any suggestions that you may have to enhance his/her future presentations.

Thank you for your feedback and time.

Dr. Julian Midgley Valerie Repper, CME Program Administrator Director, Continuing Medical Education Program Tel: (403) 955-2413 Fax: (403) 955-3045